<!doctype html>
<html>

<head>
	<meta charset="UTF-8" />
	<meta http-equiv="content-type" content="text/html; charset=utf-8" />
	<meta name="viewport" content="width=device-width, initial-scale=1.0" />

	<link rel="icon" href="images/favicon.png" />

	<title>The Purple Society</title>

	<!-- Custom -->
	<link rel="stylesheet" href="css/style.css" />
	<link rel="stylesheet" href="css/custom.css" />
</head>

<body>
	<!-- Header -->
	<header class="main-header">
		<div class="container">
			<nav class="navbar navbar-expand-md">
				<a class="navbar-brand" href="index.html">
					<img src="images/logo2.png" alt="" />
				</a>
				<button class="mobile-menu-toggle">
					<img src="images/icon/menu.svg" alt="" />
				</button>

				<div class="collapse navbar-collapse" id="navbarSupportedContent">
					<ul class="navbar-nav mr-auto">
						<li class="nav-item">
							<a class="nav-link" href="about.html">About Us</a>
						</li>
						<li class="nav-item">
							<a class="nav-link" href="guide.html">Purple Drug Guide</a>
						</li>
						<li class="nav-item dropdown">
							<a class="nav-link dropdown-toggle" href="#" id="notificationDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
								Support our Cause
							</a>
							<div class="dropdown-menu" aria-labelledby="notificationDropdown">
								<a class="dropdown-item" href="#">
									<img src="images/icon/donate2.svg" alt="" />
									<span>Donate Today</span>
								</a>
								<a class="dropdown-item" href="#">
									<img src="images/icon/time.svg" alt="" />
									<span>Volunteer Your Time</span>
								</a>
								<a class="dropdown-item" href="#">
									<img src="images/icon/support2.svg" alt="" />
									<span>Support Ai Research</span>
								</a>
								<a class="dropdown-item" href="#">
									<img src="images/icon/support3.svg" alt="" />
									Support Our Work
								</a>
							</div>
						</li>
					</ul>
					<div class="right-menu">
						<ul class="navbar-nav mr-auto">
							<li class="nav-item">
								<a class="nav-link font-weight-600" href="starred.html">
									<img src="images/icon/star.svg" alt="" /> Starred
								</a>
							</li>
						</ul>
						<ul class="navbar-nav mr-auto">
							<li class="nav-item">
								<a class="nav-link" href="#">
									<img src="images/icon/bell.svg" alt="" />
								</a>
							</li>
							<li class="nav-item">
								<a class="nav-link" href="#">
									<span class="avtar">
										<img src="images/avatar/1.png" alt="" />
									</span>
								</a>
							</li>
						</ul>
					</div>
				</div>
			</nav>
		</div>
	</header>

	<!-- Mobile Menu -->
	<div class="mobile-menu">
		<button class="mobile-menu-close">
			<img src="images/icon/close.svg" alt="" />
		</button>
		<div class="profile">
			<span class="img-sec">
				<img src="images/avatar/1.png" alt="" />
			</span>
			<div class="details-sec">
				<h5>Olivia Rhye</h5>
				<p class="m-0">olivia@teamkid.com</p>
			</div>
		</div>
		<ul class="menu-items">
			<li>
				<a href=".html">
					<img src="images/icon/profile.svg" alt="" /> My Profile
				</a>
			</li>
			<li>
				<a href=".html">
					<img src="images/icon/star-empty.svg" alt="" /> My Starred Research
				</a>
			</li>
			<li>
				<a href=".html">
					<img src="images/icon/about.svg" alt="" /> About Us
				</a>
			</li>
			<li>
				<a href=".html">
					<img src="images/icon/ai.svg" alt="" /> Purple Ai
				</a>
			</li>
			<li>
				<a href=".html">
					<img src="images/icon/guide.svg" alt="" /> The Purple Drug Guide
				</a>
			</li>
			<li>
				<a href=".html">
					<img src="images/icon/invite.svg" alt="" /> Invite a Friend
				</a>
			</li>
			<li>
				<a href=".html">
					<img src="images/icon/donate.svg" alt="" /> Donate
				</a>
			</li>
			<li>
				<a href=".html">
					<img src="images/icon/support.svg" alt="" /> Support
				</a>
			</li>
			<li>
				<a href="#">
					<img src="images/icon/logout.svg" alt="" /> Log out
				</a>
			</li>
		</ul>
	</div>

	<!-- Research One -->
	<section class="research-one">
		<div class="container">
			<div class="row">
				<div class="col-lg-10 col-12 offset-lg-1 text-left">
					<div class="ask-question">
						<h6>Have additional questions about this drug?</h6>
						<div class="ask-box">
							<div class="form-group m-0">
								<input type="text" class="form-control" placeholder="Ask your question here">
								<img src="images/icon/question.svg" alt="">
							</div>
							<button>Ask</button>
						</div>
						<p>
							Purple Ai can explore deeper questions you may have on the drug you have selected.
						</p>
					</div>
				</div>
			</div>
		</div>
	</section>

	<!-- Research Four -->
	<section class="research-four">
		<div class="container">
			<div class="row gap-2">
				<div class="col-12">
					<div class="filter-one">
						<h5>
							I’ve found these results
						</h5>
					</div>
				</div>
				<div class="col-12">
					<div class="row gap-2">
						<div class="col-md-4 col-12 offset-md-4">
							<div class="associate-box">
								<div class="head-sec">
									<div>Name</div>
									<div>Accession Number</div>
								</div>
								<div class="body-sec">
									<div>
										<img src="images/icon/check.svg" alt="" />
										<h6>Erlotnib</h6>
										<p class="m-0 fz-12">Type: Small Molecule</p>
									</div>
									<div>
										<p class="m-0">DB00530 ( APRD00951)</p>
									</div>
								</div>
							</div>
						</div>
						<div class="col-md-4">
							<div class="btn-sec">
								<div class="dropdown">
									<button class="btn btn-white-border dropdown-toggle" type="button" id="exportDropdown" data-toggle="dropdown" aria-haspopup="true"
										aria-expanded="false">
										Export as
									</button>
									<div class="dropdown-menu" aria-labelledby="exportDropdown">
										<a class="dropdown-item" href="#">
											<img src="images/icon/pdf.svg" alt="" />
											<span>PDF</span>
										</a>
										<a class="dropdown-item" href="#">
											<img src="images/icon/csv.svg" alt="" />
											<span>CSV Date</span>
										</a>
										<a class="dropdown-item" href="#">
											<img src="images/icon/bib.svg" alt="" />
											<span>BIB</span>
										</a>
									</div>
								</div>
							</div>
						</div>
					</div>
				</div>
				<div class="col-md-4">
					<div class="heading-one">
						<h1>Description</h1>
						<p>
							<b>Erlotinib hydrochloride (trade name Tarceva, Genentech/OSIP</b>, originally coded as OSI-774) is a drug used to treat non-small cell lung cancer,
							pancreatic
							cancer and several other
							types of cancer. Similar to gefitinib, erlotinib specifically targets the epidermal growth factor receptor (EGFR) tyrosine kinase. It binds in a
							reversible fashion to the adenosine
							triphosphate (ATP) binding site of the receptor. Erlotinib has recently been shown to be a potent inhibitor of JAK2V617F activity. JAK2V617F is a mutant
							of tyrosine kinase JAK2, is
							found in most patients with polycythemia vera (PV) and a substantial proportion of patients with idiopathic myelofibrosis or essential thrombocythemia.
							The study suggests that
							erlotinib may be used for treatment of JAK2V617F-positive PV and other myeloproliferative disorders.
						</p>
					</div>
				</div>
				<div class="col-md-4">
					<div class="guide-info-box">
						<h6>Indication:</h6>
						<p>
							For the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.
							Also
							for use, in combination
							with gemcitabine, as the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.
						</p>
					</div>
					<div class="guide-info-box">
						<h6>Mechanism of action:</h6>
						<p>
							The mechanism of clinical antitumor action of erlotinib is not fully characterized. Erlotinib inhibits the intracellular phosphorylation of tyrosine
							kinase
							associated with the
							epidermal growth factor receptor (EGFR). Specificity of inhibition with regard to other tyrosine kinase receptors has not been fully characterized. EGFR
							is
							expressed on the cell
							surface of normal cells and cancer cells.
						</p>
					</div>
					<div class="guide-info-box">
						<h6>Absorption:</h6>
						<p>
							Erlotinib is about 60% absorbed after oral administration and its bioavailability is substantially increased by food to almost 100%. Peak plasma levels
							occur 4 hours after dosing.
							The solubility of erlotinib is pH dependent. Solubility decreases pH increases. Smoking also decrease the exposure of erlotinib.
						</p>
					</div>
				</div>
				<div class="col-md-4">
					<div class="guide-info-box">
						<h6>Elimination:</h6>
						<p>
							Following a 100 mg oral dose, 91% of the dose was recovered in which 83% was in feces (1% of the dose as unchanged parent compound) and 8% in urine
							(0.3% of the dose as unchanged
							parent compound).
						</p>
					</div>
					<div class="guide-info-box">
						<h6>Toxicity:</h6>
						<p>
							Symptoms of overdose include diarrhea, rash, and liver transaminase elevation. The most common adverse reactions (>50%) in NSCLC are rash, diarrhea,
							anorexia and fatigue. The most
							common adverse reactions (>50%) in pancreatic cancer are fatigue, rash, nausea and anorexia.
						</p>
					</div>
					<div class="guide-info-box">
						<h6>Food Interactions:</h6>
						<ul class="disk-list">
							<li>Take at least 1 hour before or 2 hours after any food.</li>
							<li>Take with a glass of water.</li>
						</ul>
					</div>
					<div class="guide-info-box">
						<h6 style="color:#42307d;">Pharmacoeconomics:</h6>
						<p>
							Manufacturers: Osi pharmaceuticals inc <br /><br />
							Prices: <br />
							Tarceva 25 mg tablet: $52.78 tablet <br />
							Tarceva 100 mg tablet: $144.98 tablet <br />
							Tarceva 150 mg tablet: $163.98 tablet <br />
							<small>*Prices may vary. Always check with
								your medical team.</small>
						</p>
					</div>
				</div>
				<div class="col-12 text-center">
					<p class="w-1122">
						<small>
							<b>General Reference:</b> # Raymond E, Faivre S, Armand JP: Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy. Drugs.
							2000;60 Suppl 1:15-23; discussion
							41-2. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/11129168 # Li Z, Xu M, Xing S, Ho WT, Ishii T, Li Q, Fu X, Zhao ZJ: Erlotinib effectively inhibits
							JAK2V617F activity and
							polycythemia vera cell growth. J Biol Chem. 2007 Feb 9;282(6):3428-32. Epub 2006 Dec 18. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17178722 # Dudek
							AZ,
							Kmak KL, Koopmeiners J,
							Keshtgarpour M: Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously
							treated advanced or
							metastatic non-small cell lung cancer. Lung Cancer. 2006 Jan;51(1):89-96. Epub 2005 Nov 14. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/16290256 # Jones
							HE,
							Goddard L, Gee JM,
							Hiscox S, Rubini M, Barrow D, Knowlden JM, Williams S, Wakeling AE, Nicholson RI: Insulin-like growth factor-I receptor signalling and acquired
							resistance
							to gefitinib (ZD1839;
							Iressa) in human breast and prostate cancer cells. Endocr Relat Cancer. 2004 Dec;11(4):793-814. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/15613453 #
							Blum
							G, Gazit A, Levitzki A:
							Substrate competitive inhibitors of IGF-1 receptor kinase. Biochemistry. 2000 Dec 26;39(51):15705-12.
							"Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/11123895
						</small>
					</p>
				</div>
			</div>
		</div>
	</section>

	<!-- Footer -->
	<footer class="main-footer">
		<div class="container">
			<div class="row align-items-end">
				<div class="col-md-9">
					<div class="left-sec">
						<p>
							© The Purple Society, A Registered 501(c)3 Charity 2022-2023 | #273785281 <br>
							<small>
								The Purple Society website is designed for educational purposes only and is not engaged in rendering medical advice or professional services. <br>
								The information provided through this site should not be used for diagnosing or treating a health problem or a
								disease. It is not a substitute for professional care. <br>
								If you have or suspect you may have a health problem, you should consult your health care provider.
							</small>
						</p>
					</div>
				</div>
				<div class="col-md-3">
					<div class="right-sec">
						<ul class="social-one">
							<li>
								<a href="#">
									<img src="images/icon/facebook.svg" alt="" />
								</a>
							</li>
							<li>
								<a href="#">
									<img src="images/icon/twitter.svg" alt="" />
								</a>
							</li>
							<li>
								<a href="#">
									<img src="images/icon/instagram.svg" alt="" />
								</a>
							</li>
							<li>
								<a href="#">
									<img src="images/icon/linkedin.svg" alt="" />
								</a>
							</li>
							<li>
								<a href="#">
									<img src="images/icon/google.svg" alt="" />
								</a>
							</li>
						</ul>
						<a href="mailt-:help@werpurple.org">
							<img src="images/icon/envelope.svg" alt="" /> help@werpurple.org
						</a>
					</div>
				</div>
			</div>
		</div>
	</footer>

	<!-- Jquery min -->
	<script src="js/jquery.min.js"></script>

	<!-- Popper Min -->
	<script src="plugins/bootstrap/js/popper.min.js"></script>

	<!-- Bootstrap -->
	<script src="plugins/bootstrap/js/bootstrap.min.js"></script>

	<!-- Owl Carousel -->
	<script src="plugins/owl-carousel/js/owl.carousel.min.js"></script>

	<!-- Custom -->
	<script src="js/default.js"></script>

</body>

</html>